“One of the hardest things and one of the most important things is to figure out what part of urology excites you the most and look for those opportunities,” says Eila C. Skinner, MD.
In this video, Eila C. Skinner, MD, discusses why medical students should pursue the field of urology and why women especially should not be discouraged or intimidated by this subspecialty. Skinner is a urologic oncologist and Thomas A. Stamey research professor of urology at Stanford Health in Stanford, California. She is also the recipient of the Society of Urologic Oncology’s 2020 Huggins Medal, and the first woman in history to receive the award.
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.